Click Therapeutics, Inc. is a New York-based biotechnology company that specializes in developing and commercializing software as prescription medical treatments for individuals with unmet medical needs. Their digital therapeutics, designed to be used independently or in conjunction with biomedical treatments, utilize cognitive and neurobehavioral mechanisms to enable change within individuals. Click Therapeutics aims to empower patients to alter the underlying mechanisms of their conditions, targeting thoughts, sensations, emotions, and behaviors to help them achieve a healthier and happier life.
As a regulated Software as a Medical Device (SaMD) company, Click Therapeutics develops their applications in accordance with FDA, ISO, and IEC standards. They develop prescription software applications that can work independently or in conjunction with pharmacotherapies to treat various diseases. Through rigorous randomized, controlled trials, they clinically validate their applications to demonstrate safety and efficacy. Click Therapeutics seeks FDA clearance for their apps as class II medical devices with independent therapeutic treatment claims or as adjuncts to existing therapy. Physicians prescribe their apps, payers reimburse for them, and Click Therapeutics continuously generates and applies real-world evidence to personalize and improve their applications.
Generated from the website